Foley’s Representation of Biotron Included in a Texas Lawbook Deal Roundup
16 March 2022
Texas Lawbook
Texas Lawbook highlighted Foley’s work with Biotron Laboratories and Talus Mineral Company (collectively “Biotron”), two affiliated entities that in partnership manufacture and supply leading specialty minerals and nutritional ingredients, in its acquisition by Aceto, the supplier of choice for differentiated specialty materials in the life sciences and advanced technology end markets. The Foley deal team was led by Partner Alan Perkins and included Partner Julie-Anne Lutfi, Senior Counsel Emma Blumer, and Associates Anna Choi and Graham MacEwan.
Click here for the full article.
People
Related News
26 September 2024
In the News
Gregory Marino on NIL Litigation – 'Schools want to know where the line is, and now everything is in flux'
Foley & Lardner LLP special counsel Gregory Marino shared insight on the growing complexities of collegiate sports in the ABA Journal article, "Money and litigation tangle with recent rules for college athletes' NIL deals."
24 September 2024
In the News
Thomas Ferrante Assesses Recent HHS OIG Report on Remote Patient Monitoring
Foley & Lardner LLP partner Thomas Ferrante commented on the recently released report on remote patient monitoring from the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Fierce Healthcare article, “HHS watchdog flags potential remote monitoring fraud. Stakeholders say concerns about misuse are overblown.”
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."